Panacea Index Logo

Command Palette

Search for a command to run...

Experimentally-induced Wernicke's encephalopathy modifies crucial rat brain parameters: the importance of Na+, K+ -ATPase and a potentially neuroprotective role for antioxidant supplementation.

Metabolic brain disease
September 1, 2013
Apostolos Zarros et al. (9 authors)
Journal ArticleAnimal StudyMolecular Study
Extracted Claims (18)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Pre-exposure to ethanol (EtOH) consumption (20% v/v) for 5 weeks, followed by thiamine-deficient diet (TDD) and pyrithiamine (PT; 0.25 mg/kg) treatment
no change
time of WE symptomatology onset
adult rats
did not affect
provided a successful protocol modification
#1
Administration of thiamine (T; 100 mg/kg)
decrease
WE symptomatology
adult rats with induced WE
-
ameliorated
#2
Wernicke's encephalopathy (WE) induction
increase
oxidative stress
adult rats
-
provoked
#3
Administration of thiamine (T; 100 mg/kg)
decrease
oxidative stress provoked by WE
adult rats with induced WE
partially
partially limited
#4
Thiamine (T) itself
increase
oxidative stress
-
to a smaller extent
caused
#5
Wernicke's encephalopathy (WE) induction
decrease
brain acetylcholinesterase (AChE) activity
adult rats
-
found inhibited
#6
Administration of thiamine (T; 100 mg/kg)
decrease
brain acetylcholinesterase (AChE) activity
adult rats with induced WE
-
further inhibited
#7
L-carnitine (Carn)
neutral
-
in vitro brain homogenates or pure enzymes
-
demonstrated a potential neuroprotective role
#8
Wernicke's encephalopathy (WE) induction
increase
brain sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) activity
adult rats
-
found increased
#9
In vivo administration of thiamine (T; 100 mg/kg)
decrease
brain sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) activity increased by WE
adult rats with induced WE
-
reduced to control levels
#10
Exposure to pyrithiamine (PT)
increase
brain sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) activity
-
-
evident increase
#11
Exposure to thiamine-deficient diet (TDD)
increase
brain sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) activity
-
-
evident increase
#12
Exposure to ethanol (EtOH)
no change
brain sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) activity
-
-
not evident increase
#13
Thiamine (T) administration
increase
brain sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) activity
in vitro brain homogenates or pure enzymes
-
demonstrated a potential neuroprotective role through stimulation
#14
L-cysteine (Cys) administration
increase
brain sodium-potassium adenosine triphosphatase (Na+,K+-ATPase) activity
in vitro brain homogenates or pure enzymes
-
demonstrated a potential neuroprotective role through stimulation
#15
Prolonged exposure to ethanol (EtOH)
decrease
brain magnesium adenosine triphosphatase (Mg2+-ATPase) activity
adult rats
-
found decreased
#16
Experimental induction of Wernicke's encephalopathy (WE)
no change
brain magnesium adenosine triphosphatase (Mg2+-ATPase) activity
adult rats
-
not affected
#17
Combined thiamine (T) and antioxidant co-supplementation of L-cysteine (Cys) and/or L-carnitine (Carn)
neutral
examined crucial brain enzyme activities
-
to control levels
could be neuroprotective in terms of restoring
#18
Abstract

Wernicke's encephalopathy (WE) is a serious neuropsychiatric syndrome caused by chronic alcoholism and thiamine (T) deficiency. Our aim was to shed more light on the pathophysiology of WE, by introducing a modified in vivo experimental model of WE and by focusing on changes provoked in the total antioxidant status (TAS) and three crucial brain enzyme activities in adult rats. Rats were placed on ethanol (EtOH) consumption (20 % v/v) for a total of 5 weeks. By the end of the third week, rats were fed a T-deficient diet (TDD) and were treated with pyrithiamine (PT; 0.25 mg/kg) for the remaining 2 weeks. Following the induction of WE symptomatology, rats were treated with three consecutive (every 8 h) injections of saline or T (100 mg/kg) and were sacrificed. Brain homogenates were generated and used for spectrophotometrical evaluation of TAS and enzymatic activities. Additionally, in vitro experiments were conducted on brain homogenates or pure enzymes incubated with T or neuromodulatory antioxidants. Pre-exposure to EtOH provided a successful protocol modification that did not affect the expected time of WE symptomatology onset. Administration of T ameliorated this symptomatology. WE provoked oxidative stress that was partially limited by T administration, while T itself also caused oxidative stress to a smaller extent. Brain acetylcholinesterase (AChE) was found inhibited by WE and was further inhibited by T administration. In vitro experiments demonstrated a potential neuroprotective role for L-carnitine (Carn). Brain sodium-potassium adenosine triphosphatase (Na(+),K(+)-ATPase) activity was found increased in WE and was reduced to control levels by in vivo T administration; this increase was also evident in groups exposed to PT or to TDD, but not to EtOH. In vitro experiments demonstrated a potential neuroprotective role for this Na(+),K(+)-ATPase stimulation through T or L-cysteine (Cys) administration. Brain magnesium adenosine triphosphatase (Mg(2+)-ATPase) activity was found decreased by prolonged exposure to EtOH, but was not affected by the experimental induction of WE. Our data suggest that T administration inhibits AChE, which is also found inhibited in WE. Moreover, increased brain Na(+),K(+)-ATPase activity could be a marker of T deficiency in WE, while combined T and antioxidant co-supplementation of Cys and/or Carn could be neuroprotective in terms of restoring the examined crucial brain enzyme activities to control levels.

Medical Subject Headings (MeSH)
AcetylcholinesteraseAnimalsAntioxidantsBrainCa(2+) Mg(2+)-ATPaseCarnitineCysteineMaleNeuroprotective AgentsRatsRats, WistarSodium-Potassium-Exchanging ATPaseThiamine DeficiencyWernicke Encephalopathy
Study Links
PubMed ID23475222
Related Supplements